Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Anti-tuberculosis Vaccine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Taj Pharmaceuticals Limited
Serum Institute of India Pvt Ltd
Merck & Co, Inc
Solvay
GlaxoSmithKline plc
Bavarian Nordic
Informa plc
GreenSignal Bio Pharma Limited
Sanofi Pasteur SA
By Type:
Booster Vaccines
Immunotherapeutic Vaccines
By Application:
Private Clinics
Hospitals
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Anti-tuberculosis Vaccine Market Overview 2018-2029
-
1.1 China Anti-tuberculosis Vaccine Industry Development Overview
-
1.2 China Anti-tuberculosis Vaccine Industry Development History
-
1.3 China Anti-tuberculosis Vaccine Industry Market Size (2018-2029)
-
1.4 China Anti-tuberculosis Vaccine Market Analysis by Type from Production Side
-
1.4.1 China Anti-tuberculosis Vaccine Production Volume, Production Value and Growth Rate of Booster Vaccines (2018-2029)
-
1.4.2 China Anti-tuberculosis Vaccine Production Volume, Production Value and Growth Rate of Immunotherapeutic Vaccines (2018-2029)
-
1.5 China Anti-tuberculosis Vaccine Market Analysis by Application from Consumption End
-
1.5.1 China Anti-tuberculosis Vaccine Sales Volume, Sales Value and Growth Rate of Private Clinics (2018-2029)
-
1.5.2 China Anti-tuberculosis Vaccine Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.6 China Anti-tuberculosis Vaccine Market Analysis by Region
-
1.6.1 North China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
Chapter 2 China Anti-tuberculosis Vaccine Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Anti-tuberculosis Vaccine Market Status and Competition at home and abroad in 2023
-
2.2.2 China Anti-tuberculosis Vaccine Market Status and Competition Analysis in 2023
-
2.2.3 China Anti-tuberculosis Vaccine Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Anti-tuberculosis Vaccine Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Anti-tuberculosis Vaccine Industry Development
Chapter 3 Anti-tuberculosis VaccineIndustry Chain Analysis
-
3.1 Anti-tuberculosis Vaccine Industry Chain
-
3.2 Anti-tuberculosis Vaccine Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Anti-tuberculosis Vaccine Market
-
3.3 Anti-tuberculosis Vaccine Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Anti-tuberculosis Vaccine Market
Chapter 4 China Anti-tuberculosis Vaccine Market, by Type
-
4.1 China Anti-tuberculosis Vaccine Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Anti-tuberculosis Vaccine Total Production Volume and Growth Rate from Production Side
-
4.5 China Anti-tuberculosis Vaccine Production Volume and Growth Rate, by Type
-
4.5.1 China Anti-tuberculosis Vaccine Production Volume and Growth Rate of Booster Vaccines
-
4.5.2 China Anti-tuberculosis Vaccine Production Volume and Growth Rate of Immunotherapeutic Vaccines
Chapter 5 China Anti-tuberculosis Vaccine Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Anti-tuberculosis Vaccine Total Market Size and Growth Rate from Consumption End
-
5.5 China Anti-tuberculosis Vaccine Market Size and Growth Rate, by Application
-
5.5.1 China Anti-tuberculosis Vaccine Market Size and Growth Rate of Private Clinics
-
5.5.2 China Anti-tuberculosis Vaccine Market Size and Growth Rate of Hospitals
Chapter 6 China Anti-tuberculosis Vaccine Market, by Region
-
6.1 China Anti-tuberculosis Vaccine Production Volume and Production Value, by Region
-
6.2 China Anti-tuberculosis Vaccine Sales Volume and Sales Value, by Region
Chapter 7 North China Anti-tuberculosis Vaccine Market Analysis
-
7.1 North China Anti-tuberculosis Vaccine Market, by Type
-
7.2 North China Anti-tuberculosis Vaccine Market, by Application
Chapter 8 Central China Anti-tuberculosis Vaccine Market Analysis
-
8.1 Central China Anti-tuberculosis Vaccine Market, by Type
-
8.2 Central China Anti-tuberculosis Vaccine Market, by Application
Chapter 9 South China Anti-tuberculosis Vaccine Market Analysis
-
9.1 South China Anti-tuberculosis Vaccine Market, by Type
-
9.2 South China Anti-tuberculosis Vaccine Market, by Application
Chapter 10 East China Anti-tuberculosis Vaccine Market Analysis
-
10.1 East China Anti-tuberculosis Vaccine Market, by Type
-
10.2 East China Anti-tuberculosis Vaccine Market, by Application
Chapter 11 Northeast China Anti-tuberculosis Vaccine Market Analysis
-
11.1 Northeast China Anti-tuberculosis Vaccine Market, by Type
-
11.2 Northeast China Anti-tuberculosis Vaccine Market, by Application
Chapter 12 Southwest China Anti-tuberculosis Vaccine Market Analysis
-
12.1 Southwest China Anti-tuberculosis Vaccine Market, by Type
-
12.2 Southwest China Anti-tuberculosis Vaccine Market, by Application
Chapter 13 Northwest China Anti-tuberculosis Vaccine Market Analysis
-
13.1 Northwest China Anti-tuberculosis Vaccine Market, by Type
-
13.2 Northwest China Anti-tuberculosis Vaccine Market, by Application
Chapter 14 Company Profiles
-
14.1 Taj Pharmaceuticals Limited
-
14.1.1 Taj Pharmaceuticals Limited Company Profile
-
14.1.2 Taj Pharmaceuticals Limited Anti-tuberculosis Vaccine Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Serum Institute of India Pvt Ltd
-
14.2.1 Serum Institute of India Pvt Ltd Company Profile
-
14.2.2 Serum Institute of India Pvt Ltd Anti-tuberculosis Vaccine Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Merck & Co, Inc
-
14.3.1 Merck & Co, Inc Company Profile
-
14.3.2 Merck & Co, Inc Anti-tuberculosis Vaccine Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Solvay
-
14.4.1 Solvay Company Profile
-
14.4.2 Solvay Anti-tuberculosis Vaccine Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 GlaxoSmithKline plc
-
14.5.1 GlaxoSmithKline plc Company Profile
-
14.5.2 GlaxoSmithKline plc Anti-tuberculosis Vaccine Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Bavarian Nordic
-
14.6.1 Bavarian Nordic Company Profile
-
14.6.2 Bavarian Nordic Anti-tuberculosis Vaccine Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Informa plc
-
14.7.1 Informa plc Company Profile
-
14.7.2 Informa plc Anti-tuberculosis Vaccine Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 GreenSignal Bio Pharma Limited
-
14.8.1 GreenSignal Bio Pharma Limited Company Profile
-
14.8.2 GreenSignal Bio Pharma Limited Anti-tuberculosis Vaccine Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Sanofi Pasteur SA
-
14.9.1 Sanofi Pasteur SA Company Profile
-
14.9.2 Sanofi Pasteur SA Anti-tuberculosis Vaccine Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Anti-tuberculosis Vaccine Industry Research Conclusions
-
15.2 Anti-tuberculosis Vaccine Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Anti-tuberculosis Vaccine Industry Market Size (2018-2029)
-
Figure China Anti-tuberculosis Vaccine Production Volume, Production Value and Growth Rate of Booster Vaccines (2018-2029)
-
Figure China Anti-tuberculosis Vaccine Production Volume, Production Value and Growth Rate of Immunotherapeutic Vaccines (2018-2029)
-
Figure China Anti-tuberculosis Vaccine Sales Volume, Sales Value and Growth Rate of Private Clinics (2018-2029)
-
Figure China Anti-tuberculosis Vaccine Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure North China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Central China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
Figure South China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
Figure East China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Anti-tuberculosis Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Anti-tuberculosis Vaccine Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Anti-tuberculosis Vaccine Market Share by Type in 2018
-
Figure China Anti-tuberculosis Vaccine Market Share by Type in 2023
-
Figure China Anti-tuberculosis Vaccine Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Anti-tuberculosis Vaccine Production Volume and Growth Rate of Booster Vaccines (2018-2023)
-
Figure China Anti-tuberculosis Vaccine Production Volume and Growth Rate of Immunotherapeutic Vaccines (2018-2023)
-
Figure China Anti-tuberculosis Vaccine Market Share by Application in 2018
-
Figure China Anti-tuberculosis Vaccine Market Share by Application in 2023
-
Figure China Anti-tuberculosis Vaccine Total Market Size and Growth Rate from Consumption End
-
Figure China Anti-tuberculosis Vaccine Market Size and Growth Rate of Private Clinics (2018-2023)
-
Figure China Anti-tuberculosis Vaccine Market Size and Growth Rate of Hospitals (2018-2023)
-
Table China Anti-tuberculosis Vaccine Production Volume by Region (2018-2023)
-
Table China Anti-tuberculosis Vaccine Production Volume Share by Region (2018-2023)
-
Figure China Anti-tuberculosis Vaccine Production Volume Share by Region (2018-2023)
-
Table China Anti-tuberculosis Vaccine Production Value by Region (2018-2023)
-
Table China Anti-tuberculosis Vaccine Production Value Share by Region (2018-2023)
-
Figure China Anti-tuberculosis Vaccine Production Value Share by Region (2018-2023)
-
Table China Anti-tuberculosis Vaccine Sales Volume by Region (2018-2023)
-
Table China Anti-tuberculosis Vaccine Sales Volume Share by Region (2018-2023)
-
Figure China Anti-tuberculosis Vaccine Sales Volume Share by Region (2018-2023)
-
Table China Anti-tuberculosis Vaccine Sales Value by Region (2018-2023)
-
Table China Anti-tuberculosis Vaccine Sales Value Share by Region (2018-2023)
-
Figure China Anti-tuberculosis Vaccine Sales Value Share by Region (2018-2023)
-
Table North China Anti-tuberculosis Vaccine Production Volume by Type (2018-2023)
-
Table North China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Figure North China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Table North China Anti-tuberculosis Vaccine Sales Volume by Application (2018-2023)
-
Table North China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Figure North China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Table Central China Anti-tuberculosis Vaccine Production Volume by Type (2018-2023)
-
Table Central China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Figure Central China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Table Central China Anti-tuberculosis Vaccine Sales Volume by Application (2018-2023)
-
Table Central China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Central China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Table South China Anti-tuberculosis Vaccine Production Volume by Type (2018-2023)
-
Table South China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Figure South China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Table South China Anti-tuberculosis Vaccine Sales Volume by Application (2018-2023)
-
Table South China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Figure South China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Table East China Anti-tuberculosis Vaccine Production Volume by Type (2018-2023)
-
Table East China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Figure East China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Table East China Anti-tuberculosis Vaccine Sales Volume by Application (2018-2023)
-
Table East China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Figure East China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Table Northeast China Anti-tuberculosis Vaccine Production Volume by Type (2018-2023)
-
Table Northeast China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Figure Northeast China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Table Northeast China Anti-tuberculosis Vaccine Sales Volume by Application (2018-2023)
-
Table Northeast China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Table Southwest China Anti-tuberculosis Vaccine Production Volume by Type (2018-2023)
-
Table Southwest China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Figure Southwest China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Table Southwest China Anti-tuberculosis Vaccine Sales Volume by Application (2018-2023)
-
Table Southwest China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Table Northwest China Anti-tuberculosis Vaccine Production Volume by Type (2018-2023)
-
Table Northwest China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Figure Northwest China Anti-tuberculosis Vaccine Production Volume Share by Type (2018-2023)
-
Table Northwest China Anti-tuberculosis Vaccine Sales Volume by Application (2018-2023)
-
Table Northwest China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Anti-tuberculosis Vaccine Sales Volume Share by Application (2018-2023)
-
Table Taj Pharmaceuticals Limited Company Profile
-
Table Taj Pharmaceuticals Limited Anti-tuberculosis Vaccine Revenue, Price and Gross (2018-2023)
-
Table Serum Institute of India Pvt Ltd Company Profile
-
Table Serum Institute of India Pvt Ltd Anti-tuberculosis Vaccine Revenue, Price and Gross (2018-2023)
-
Table Merck & Co, Inc Company Profile
-
Table Merck & Co, Inc Anti-tuberculosis Vaccine Revenue, Price and Gross (2018-2023)
-
Table Solvay Company Profile
-
Table Solvay Anti-tuberculosis Vaccine Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline plc Company Profile
-
Table GlaxoSmithKline plc Anti-tuberculosis Vaccine Revenue, Price and Gross (2018-2023)
-
Table Bavarian Nordic Company Profile
-
Table Bavarian Nordic Anti-tuberculosis Vaccine Revenue, Price and Gross (2018-2023)
-
Table Informa plc Company Profile
-
Table Informa plc Anti-tuberculosis Vaccine Revenue, Price and Gross (2018-2023)
-
Table GreenSignal Bio Pharma Limited Company Profile
-
Table GreenSignal Bio Pharma Limited Anti-tuberculosis Vaccine Revenue, Price and Gross (2018-2023)
-
Table Sanofi Pasteur SA Company Profile
-
Table Sanofi Pasteur SA Anti-tuberculosis Vaccine Revenue, Price and Gross (2018-2023)
-
